Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Myopathy, Cognitive Impairment
Interventions: Biopsy/Ultrasound; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Secondary Immune Deficiency
Interventions: 20% subcutaneous immunoglobulin; Drug
Lead sponsor: Rochester General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Dasatinib, Quercetin; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastroparesis, Gastroparesis-like Syndrome
Interventions: Not listed
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 8 Years to 25 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Boston, Massachusetts • Columbus, Ohio • El Paso, Texas + 2 more

Conditions: Traumatic Brain Injury, Post-concussion Syndrome
Interventions: Not listed
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Angioedema, Angioedemas, Hereditary, Urticaria, Mastocytosis, ACE Inhibitor-Induced Angioedema, C1 Inhibitor Deficiency, Systemic Mastocytoses, Indolent Systemic Mastocytosis
Interventions: Venipuncture; Diagnostic Test
Lead sponsor: Foundation For Rare Disease Research; Other
Eligibility: 12 Years to 75 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Wheaton, Maryland

Conditions: Dysmenorrhea, Dyspareunia, Endometriosis, Pelvic Pain
Interventions: ERB-041; Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 49
States / cities: Montgomery, Alabama • Chandler, Arizona • Phoenix, Arizona + 41 more

Conditions: Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction, Cardiovascular Disease
Interventions: Leuprolide acetate, Estradiol, Medroxyprogesterone, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Aurora, Colorado • Boulder, Colorado

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Liver Disease
Interventions: Efinopegdutide; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 36
States / cities: Chandler, Arizona • Peoria, Arizona • Tucson, Arizona + 27 more

Conditions: Critical Illness, Intensive Care Unit Delirium
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 567 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 2
States / cities: Chicago, Illinois • Nashville, Tennessee

Conditions: Impaired Cognition, Chemo-brain, Breast Cancer
Interventions: Cognitive, functional and subjective assessments, MRI, PET Scan; Other · Device · Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts • Salem, Massachusetts

Conditions: Urinary Dysfunction, Lower Urinary Tract Symptoms, Urinary Tract Infections, Urinary Tract Infections in Children
Interventions: Bladder Health Education; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 5 Years to 10 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2028 – 2033
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Sarcopenia
Interventions: DXA scanning, CT imaging; Radiation
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 45 Years to 85 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Alzheimer Disease
Interventions: F 18 T807 Flortaucipir; Drug
Lead sponsor: Tammie L. S. Benzinger, MD, PhD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Platelet Dysfunction Due to Aspirin Ingestion
Interventions: Not listed
Lead sponsor: Aggredyne, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment (MCI), Parkinsons Disease (PD), Healthy Adult
Interventions: transcutaneous auricular vagus nerve stimulation, sham stimulation; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Congestive Heart Failure, Renal Dysfunction
Interventions: low dose Nesiritide, nesiritide, Sildenafil; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Rochester, Minnesota

Conditions: Renal Transplant Recipients
Interventions: Not listed
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 21 Years to 65 Years · Male only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Covid19, Anxiety, Mood, Cognitive Impairment
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease, Cognitive Impairment
Interventions: Routine care, Coaching plus routine care; Behavioral · Other
Lead sponsor: Hoag Memorial Hospital Presbyterian; Other
Eligibility: 50 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Type 2 Diabetes, Type 2 Diabetes (T2DM)
Interventions: Eroxon®, tadalafil; Device · Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Erectile Dysfunction With Diabetes Mellitus
Interventions: Shockwave Therapy (SWT), Autologous Platelet-Rich Plasma (PRP); Device · Drug
Lead sponsor: University of Miami; Other
Eligibility: 30 Years to 80 Years · Male only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Schizophrenia Spectrum and Other Psychotic Disorders, Cognitive Impairment
Interventions: rTMS, Computerized cognitive training; Device · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Apical Ballooning Syndrome
Interventions: PET scan; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness

Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig

ALSENLITE: Senolytics for Alzheimer's Disease

GpCRC Pediatric Gastroparesis Registry 2

Measure of Cerebrovascular Dysfunction After TBI With fNIRS

Angioedema Biomarker Research Study

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction in ICU Survivors, 2nd Study

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

School-Based Bladder Health Intervention

Screening for Age-Related Skeletal Muscle Dysfunction

Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.

AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction

Sexual Function in Male Renal Transplant Patients

COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes

Coaching for Cognition in Alzheimer's (COCOA)

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

Cardiac Sympathetic Activity in Patients With the Apical Ballooning Syndrome